Mirabella Financial Services LLP Incyte Corp Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$57.77 - $65.93 $210,802 - $240,578
3,649 New
3,649 $210,000
Q4 2022

Feb 13, 2023
BUY
$67.18 - $84.11 $1.59 Million - $2 Million
23,736 Added 168.46%
37,826 $3.04 Million
Q3 2022

Oct 26, 2022
BUY
$66.18 - $82.86 $932,476 - $1.17 Million
14,090 New
14,090 $939,000
Q4 2020

Feb 16, 2021
SELL
$80.74 - $97.7 $371,807 - $449,908
-4,605 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$85.07 - $109.69 $391,747 - $505,122
4,605 New
4,605 $413,000

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email